Gary Michael Myles

Gary Michael Myles, located in Issaquah, Washington, excels as a biotechnology patent attorney. He adeptly drafts and prosecutes patent applications across various life sciences inventions, tailoring intellectual property strategies for clients ranging from universities and non-profits to start-ups and established bio/pharma companies. His expertise extends to formulating freedom-to-operate, non-infringement, and invalidity opinions, as well as conducting thorough intellectual property due diligence reviews. Gary's technological proficiency encompasses molecular and cell biology, biochemistry, virology, cell biology, immunology, nanotechnology, and personalized medicine.

Gary's scientific background is robust, with post-doctoral research at the Fred Hutchinson Cancer Research Center in Seattle focusing on molecular mechanisms of signal transduction. His graduate research at the University of North Carolina in Chapel Hill culminated in a Ph.D. in biochemistry and biophysics. His dissertation, "Structure-Function Studies on Uvra: An Escherichia coli DNA Repair Protein," was conducted under Aziz Sancar, a 2015 Nobel Prize in Chemistry laureate.

Before his graduate studies, Dr. Myles contributed to the Hepatitis/HIV division at Abbott Laboratories. He also pursued graduate coursework in chemical engineering at the University of Michigan in Ann Arbor and earned a B.S. in biochemistry from the University of Illinois in Urbana/Champaign.

In addition to his legal practice, Gary serves as an adjunct professor of law at Seattle University, teaching Biotechnology and the Law. He also holds an adjunct professorship and is a Law, Technology, and Arts Fellow at the University of Washington, where he instructs on Advanced Patent Law. Gary earned his J.D. from the University of Washington and is admitted to practice in the Washington State Bar, District Court for the Western District of Washington, and United States Patent and Trademark Office.